semaglutide for obesity shreveport Landry vetoes weight-loss drug insurance coverage state employees, teachers Medical Weight Loss Shreveport |
Description
Sleep disturbances affect up to 30% of people starting GLP-1 therapy
Eli Lilly and Company has announced topline results from the SURMOUNT-5 phase 3b open-label randomised clinical trial that found Zepbound (tirzepatide) provided a 47% greater relative weight loss vs
Link to full study here
Used in diabetes &
And the clinical results have been impressive
Semaglutide Side Effects and Potential Long-Term Risks Common side effects of Semaglutide include: Nausea Diarrhea Vomiting Stomach pain Constipation These side effects are mild and tend to improve over time as your body adjusts to the medication
